{"id":1737,"date":"2017-12-08T12:29:11","date_gmt":"2017-12-08T12:29:11","guid":{"rendered":"http:\/\/ablinc.com\/product\/import-placeholder-for-1406\/"},"modified":"2023-01-03T20:15:37","modified_gmt":"2023-01-03T20:15:37","slug":"5427-hiv-1-451-gp160-native","status":"publish","type":"product","link":"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/","title":{"rendered":"5427 – HIV-1 451 gp160 (Native)"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Viral Proteins Safety Data Sheet<\/a><\/p>\n

Quantity: 100 \u03bcg<\/p>\n

The conditioned medium of HIV-1451infected cells. The gp160 is secreted in the medium. The protein is an oligomer and is probably truncated near the transmembrane domain and runs as a 140 kDa protein in SDS-PAGE.<\/p>\n","protected":false},"featured_media":5259,"template":"","meta":{"_acf_changed":false},"product_cat":[84,52,25],"product_tag":[],"acf":[],"yoast_head":"\n5427 - HIV-1 451 gp160 (Native) - ABL, Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"5427 - HIV-1 451 gp160 (Native) - ABL, Inc.\" \/>\n<meta name=\"twitter:description\" content=\"Viral Proteins Safety Data Sheet Quantity: 100 \u03bcg The conditioned medium of HIV-1451infected cells. The gp160 is secreted in the medium. The protein is an oligomer and is probably truncated near the transmembrane domain and runs as a 140 kDa protein in SDS-PAGE.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/Viral-cat-1.jpg\" \/>\n<meta name=\"twitter:site\" content=\"@ABL_Inc\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/\",\"url\":\"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/\",\"name\":\"5427 - HIV-1 451 gp160 (Native) - ABL, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/ablinc.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/Viral-cat-1.jpg\",\"datePublished\":\"2017-12-08T12:29:11+00:00\",\"dateModified\":\"2023-01-03T20:15:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/#primaryimage\",\"url\":\"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/Viral-cat-1.jpg\",\"contentUrl\":\"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/Viral-cat-1.jpg\",\"width\":457,\"height\":363,\"caption\":\"Viral catalog research products\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\/\/ablinc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\/\/ablinc.com\/shop\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"5427 – HIV-1 451 gp160 (Native)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ablinc.com\/#website\",\"url\":\"https:\/\/ablinc.com\/\",\"name\":\"ABL, Inc.\",\"description\":\"Advancing Vaccines and BioTherapeutics\",\"publisher\":{\"@id\":\"https:\/\/ablinc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ablinc.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ablinc.com\/#organization\",\"name\":\"ABL inc.\",\"url\":\"https:\/\/ablinc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ablinc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/logo.png\",\"contentUrl\":\"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/logo.png\",\"width\":706,\"height\":188,\"caption\":\"ABL inc.\"},\"image\":{\"@id\":\"https:\/\/ablinc.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ABL_Inc\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"5427 - HIV-1 451 gp160 (Native) - ABL, Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/","twitter_card":"summary_large_image","twitter_title":"5427 - HIV-1 451 gp160 (Native) - ABL, Inc.","twitter_description":"Viral Proteins Safety Data Sheet Quantity: 100 \u03bcg The conditioned medium of HIV-1451infected cells. The gp160 is secreted in the medium. The protein is an oligomer and is probably truncated near the transmembrane domain and runs as a 140 kDa protein in SDS-PAGE.","twitter_image":"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/Viral-cat-1.jpg","twitter_site":"@ABL_Inc","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/","url":"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/","name":"5427 - HIV-1 451 gp160 (Native) - ABL, Inc.","isPartOf":{"@id":"https:\/\/ablinc.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/#primaryimage"},"image":{"@id":"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/#primaryimage"},"thumbnailUrl":"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/Viral-cat-1.jpg","datePublished":"2017-12-08T12:29:11+00:00","dateModified":"2023-01-03T20:15:37+00:00","breadcrumb":{"@id":"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/#primaryimage","url":"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/Viral-cat-1.jpg","contentUrl":"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/Viral-cat-1.jpg","width":457,"height":363,"caption":"Viral catalog research products"},{"@type":"BreadcrumbList","@id":"https:\/\/ablinc.com\/product\/5427-hiv-1-451-gp160-native\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/ablinc.com\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/ablinc.com\/shop\/"},{"@type":"ListItem","position":3,"name":"5427 – HIV-1 451 gp160 (Native)"}]},{"@type":"WebSite","@id":"https:\/\/ablinc.com\/#website","url":"https:\/\/ablinc.com\/","name":"ABL, Inc.","description":"Advancing Vaccines and BioTherapeutics","publisher":{"@id":"https:\/\/ablinc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ablinc.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ablinc.com\/#organization","name":"ABL inc.","url":"https:\/\/ablinc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ablinc.com\/#\/schema\/logo\/image\/","url":"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/logo.png","contentUrl":"https:\/\/ablinc.com\/\/home\/197474.cloudwaysapps.com\/pndxcqmahh\/public_html\/assets\/logo.png","width":706,"height":188,"caption":"ABL inc."},"image":{"@id":"https:\/\/ablinc.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ABL_Inc"]}]}},"_links":{"self":[{"href":"https:\/\/ablinc.com\/wp-json\/wp\/v2\/product\/1737"}],"collection":[{"href":"https:\/\/ablinc.com\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/ablinc.com\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ablinc.com\/wp-json\/wp\/v2\/media\/5259"}],"wp:attachment":[{"href":"https:\/\/ablinc.com\/wp-json\/wp\/v2\/media?parent=1737"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/ablinc.com\/wp-json\/wp\/v2\/product_cat?post=1737"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/ablinc.com\/wp-json\/wp\/v2\/product_tag?post=1737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}